Intranasal application of glucocorticoid alleviates olfactory dysfunction in mice with allergic rhinitis

Wang,Xiaowei; Zhu,Yingying; Ni,Daofeng; Lv,Wei; Gao,Zhiqiang; Qi,Fang

doi:10.3892/etm.2017.5042

Intranasal application of glucocorticoid alleviates olfactory dysfunction in mice with allergic rhinitis

Authors:
- Xiaowei Wang
- Yingying Zhu
- Daofeng Ni
- Wei Lv
- Zhiqiang Gao
- Fang Qi
View Affiliations

Affiliations: Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, P.R. China
Published online on: August 28, 2017 https://doi.org/10.3892/etm.2017.5042
Pages: 3971-3978
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effect of glucocorticoid intervention on olfactory dysfunction in mice with allergic rhinitis (AR). An AR animal model was established by intraperitoneal injection and intranasal application of ovalbumin to mice. The olfactory function of the mice was evaluated using a buried food test, and morphological changes in the nasal mucosa were determined using hematoxylin and eosin staining. The expression of olfactory marker protein (OMP) in the olfactory mucosa was tested by immunohistochemistry, and was observed on days 7 and 14 after the application of glucocorticoid. The incidence rate of olfactory dysfunction in AR mice was 75.34%, and the olfactory epithelium became thinner in mice with AR compared to the control group. In addition, the expression of OMP in the olfactory epithelium was downregulated in mice with AR compared with the control group. Expression of OMP in the olfactory epithelium was upregulated in the budesonide group A and betamethasone group A compared with the medicine‑free group, whereas the expression of OMP in the olfactory epithelium of budesonide group A or betamethasone group A was not significantly different from the control group. Moreover, the expression of OMP in the budesonide group B was similar to budesonide group A, and expression of OMP in betamethasone group B was similar to betamethasone group A. The expression of OMP in olfactory mucosa is downregulated in AR mice with olfactory dysfunction. Following the application of glucocorticoid, the expression of OMP in the olfactory mucosa in mice is upregulated. Moreover, intranasal local glucocorticoid has a low incidence of systemic adverse reactions, and is recommended for the treatment of olfactory dysfunction in AR.

View Figures

View References

1	Ni DF: Olfactory disorders and olfactory function test. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 17:571–575. 2003.(In Chinese).
2	Stenner M, Vent J, Huttenbrink KB, Hummel T and Damm M: Topical therapy in anosmia: Relevance of steroid-responsiveness. Laryngoscope. 18:1681–1686. 2008. View Article : Google Scholar
3	Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, et al: Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the world health organization, GA(2)LEN and AllerGen). Allergy. 86 Suppl 63:86–160. 2008.
4	Guilemany JM, García-Piñero A, Alobid I, Cardelús S, Centellas S, Bartra J, Valero A, Picado C and Mullol J: Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammation. Laryngoscope. 119:233–238. 2009. View Article : Google Scholar : PubMed/NCBI
5	Gu ZY: Respiratory tract inflammation. Zhonghua Er Bi Yan Hou Ke Za Zhi. 36:397–399. 2001.(In Chinese).
6	Amit A, Saxena VS, Pratibha N, D'Souza P, Bagchi M, Bagchi D and Stohs SJ: Mast cell stabilization, lipoxygenase inhibition, hyaluronidase inhibition, antihistaminic and antispasmodic activities of Aller-7, a novel botanical formulation for allergic rhinitis. Drugs Exp Clin Res. 29:107–115. 2003.PubMed/NCBI
7	Mott AE, Cain WS, Lafreniere D, Leonard G, Gent JF and Frank ME: Topical corticosteroid treatment of anosmia associated with nasal and sinus disease. Arch Otolaryngol Head Neck Surg. 123:367–372. 1997. View Article : Google Scholar : PubMed/NCBI
8	Simola M and Malmberg H: Sense of smell in allergic and nonallergic rhinitis. Allergy. 53:190–194. 1998. View Article : Google Scholar : PubMed/NCBI
9	Kirtsreesakul V and Naclerio RM: Role of allergy in rhinosinusitis. Curr Opin Allergy Clin Immunol. 4:17–23. 2004. View Article : Google Scholar : PubMed/NCBI
10	Moll B, Klimek L, Eggers G and Mann W: Comparison of olfactory function in patients with seasonal and perennial allergic rhinitis. Allergy. 53:297–301. 1998. View Article : Google Scholar : PubMed/NCBI
11	Cowart BJ, Flynn-Rodden K, McGeady SJ and Lowry LD: Hyposmia in allergic rhinitis. J Allergy Clin Immunol. 91:747–751. 1993. View Article : Google Scholar : PubMed/NCBI
12	Rombaux P, Collet S, Eloy P, Ledeghen S and Bertrand B: Smell disorders in ENT clinic. B-ENT. 1 Suppl 1:97–109. 2005.PubMed/NCBI
13	Doty RL and Mishra A: Olfactory and its alteration by nasal obstruction, rhinitis, and rhinosinusitis. Laryngoscope. 111:409–423. 2001. View Article : Google Scholar : PubMed/NCBI
14	Guss J, Doghramji L, Reger C and Chiu AG: Olfactory dysfunction in allergic rhinitis. ORL J Otorhinolaryngol Relat Spec. 71:268–272. 2009. View Article : Google Scholar : PubMed/NCBI
15	van Beek TA and Montoro P: Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals. J Chromatogr A. 1216:2002–2032. 2009. View Article : Google Scholar : PubMed/NCBI
16	Berghard A, Buck LB and Liman ER: Evidence for distinct signaling mechanisms in two mammalian olfactory sense organ. Proc Natl Acad Sci USA. 93:2365–2369. 1996. View Article : Google Scholar : PubMed/NCBI
17	Buck LB: The molecular architecture of odor and pheromone sensing in mammals. Cell. 100:611–618. 2000. View Article : Google Scholar : PubMed/NCBI
18	Kass MD, Moberly AH, Rosenthal MC, Guang SA and McGann JP: Odor-specific, olfactory marker protein-mediated sparsening of primary olfactory input to the brain after odor exposure. J Neurosci. 33:6594–6602. 2013. View Article : Google Scholar : PubMed/NCBI
19	Lee AC, He J and Ma M: Olfactory marker protein is critical for functional maturation of olfactory sensory neurons and development of mother preference. J Neurosci. 31:2974–2982. 2011. View Article : Google Scholar : PubMed/NCBI
20	Faulcon P, Biacabe B and Bonfils P: Contribution of corticosteroid treatment in neurosensorial anosomia: A series of 62 patients. Ann Otolaryngol Chir Cervicofac. 117:374–377. 2000.(In French). PubMed/NCBI
21	Heilmann S, Huettenbrink KB and Hummel T: Local and systemic administration of corticosteroid in the treatment of olfactory loss. Am J Rhinol. 18:29–33. 2004.PubMed/NCBI
22	Stevens MH: Steroid-dependent anosmia. Laryngoscope. 111:200–203. 2001. View Article : Google Scholar : PubMed/NCBI
23	Hilberg O: Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge. Allergy. 50:683–688. 1995. View Article : Google Scholar : PubMed/NCBI
24	Guan J, Ni DF, Wang J, Zhu Y, Xu C, Chen X and Liu J: Therapy for olfactory disorder associated with URTI along with nasal and accessory nasal diseases. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 24:484–488. 2010.(In Chinese). PubMed/NCBI
25	Miescher SM and Vogel M: Molecular aspects of allergy. Mol Aspects Med. 23:413–462. 2002. View Article : Google Scholar : PubMed/NCBI
26	Takahashi N, Aramaki Y and Tsuchiy S: Allergic rhinitis model with Brown Norway rat and evaluation of antiallergic drugs. J Pharmacobiodyn. 13:414–420. 1990. View Article : Google Scholar : PubMed/NCBI
27	Nakaya M, Dohi M, Okunishi K, Nakagome K, Tanaka R, Imamura M, Baba S, Takeuchi N, Yamamoto K and Kaga K: Noninvasive system for evaluating allergen-induced nasal hypersensitivity in murine allergic rhinitis. Lab Invest. 86:917–926. 2006. View Article : Google Scholar : PubMed/NCBI
28	Tanaka K, Okamoto Y, Nagaya Y, Nishimura F, Takeoka A, Hanada S, Kohno S and Kawai M: A nasal allergy model developed in the guinea pig by application of 2,4-toluene diisocyanate. Int Arch Allergy Appl Immunol. 85:392–397. 1988. View Article : Google Scholar : PubMed/NCBI
29	Sehmi R, Wood LJ, Watson R, Foley R, Hamid Q, O'Byrne PM and Denburg JA: Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest. 100:2466–2475. 1997. View Article : Google Scholar : PubMed/NCBI
30	Lin J, Wei YX, Wang XD and Yang L: Observation of the olfactory mucosa in mice with allergic rhinitis olfactory dysfunction. Zhongguo Er Bi Yan Hou Tou Jing Wai Ke. 15:465–468. 2008.(In Chinese).
31	Carr VM, Robinson AM and Kern RC: Tissue-specific effects of allergic rhinitis in mouse nasal epithelia. Chem Senses. 37:655–668. 2012. View Article : Google Scholar : PubMed/NCBI
32	Wirth S, Stemmelin J, Will B, Christen YVES and Di Scala G: Facilitative effects of EGb 761 on olfactory recognition in young and aged rats. Pharmacol Biochem Behav. 65:321–326. 2000. View Article : Google Scholar : PubMed/NCBI
33	Nathan BP, Yost J, Litherland MT, Struble RG and Switzer PV: Olfactory function in apoE knockout mice. Behav Brain Res. 150:1–7. 2004. View Article : Google Scholar : PubMed/NCBI
34	Liebenauer LL and Slotnick BM: Social organization and aggression in a group of olfactory bulbectomized male mice. Physiol Behav. 60:403–409. 1996. View Article : Google Scholar : PubMed/NCBI
35	Seiden AM and Duncan HJ: The diagnosis of a conductive olfactory loss. Laryngoscope. 111:9–14. 2001. View Article : Google Scholar : PubMed/NCBI
36	Klimek L and Eggers G: Olfactory dysfunction in allergic rhinitis is related to nasal eosinophilic inflammation. J Allergy Clin Immunol. 100:158–164. 1997. View Article : Google Scholar : PubMed/NCBI
37	Doty RL and Mishra A: Olfaction and its alternation by nasal obstruction, rhinitis, and rhinosinusitis. Laryngoscope. 111:409–423. 2001. View Article : Google Scholar : PubMed/NCBI
38	Chen ZH and Ni DF: Research progress of odorant receptor. Guo Ji Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 15:465–468. 2008.(In Chinese).
39	Hummel T, Rissom K, Reden J, Hähner A, Weidenbecher M and Hüttenbrink KB: Effects of olfactory training in patients with olfactory loss. Laryngoscope. 119:496–499. 2009. View Article : Google Scholar : PubMed/NCBI
40	Henkin RI, Potolicchio SJ Jr and Levy LM: Improvement in smell and taste dysfunction after repetitive transcranial magnetic stimulation. Am J Otolarnygol. 32:38–46. 2011. View Article : Google Scholar
41	Hotchkiss WT: Influence of prednisone on nasal polyposis with anosmia; preliminary report. AMA Arch Otolaryngol. 64:478–479. 1956. View Article : Google Scholar : PubMed/NCBI
42	Fukazawa K, Fujii M, Tomofuji S, Ogasawara H, Seo W and Sakagami M: Local injection of dexamethasone acetate suspension into the nasal mucosa in cases of olfactory disturbance. Nippon Jibinkoka Gakkai Kaiho. 102:1175–1183. 1999.(In Japanese). View Article : Google Scholar
43	Seo BS, Lee HJ, Mo JH, Lee CH, Rhee CS and Kim JW: Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray. Arch Otolaryngol Head Neck Surg. 135:1000–1004. 2009. View Article : Google Scholar : PubMed/NCBI
44	Lee GS, Cho JH, Park CS, Jung SH, Lee DH, Jun BC, Song CE and Cho KJ: The effect of Ginkgo biloba on the expression of intermediate-early antigen (c-fos) in the experimentally induced anosmic mouse. Auris Nasus Larynx. 36:287–291. 2009. View Article : Google Scholar : PubMed/NCBI
45	Robinson AM, Kern RC, Foster JD, Fong KJ and Pitovski DZ: Expression of glucocorticoid receptor mRNA and protein in the olfactory mucosa: Physiologic and pathophysiologic implications. Laryngoscope. 108:1238–1242. 1998. View Article : Google Scholar : PubMed/NCBI
46	Takanosawa M, Nishino H, Ohta Y and Ichimura K: Glucocorticoids enhance regeneration of murine olfactory epithelium. Acta Otolaryngol. 129:1002–1009. 2009. View Article : Google Scholar : PubMed/NCBI
47	Wei Y, Zhang C, Miao X, Xing F, Liu X, Zhao H, Zhan X and Han D: Effects of glucocorticoid on cyclic nucleotide-gated channels of olfactory receptor neurons. J Otolaryngol Head Neck Surg. 38:90–95. 2009.PubMed/NCBI